| CETUXIMAB |
西妥昔单抗 |
205923-56-4 |
| Tubulysin A,TubA |
N-(2-氨基-2-氧代乙基)-N-(羧甲基)甘氨酸 |
205304-86-5 |
| Bortezomib intermediates II |
(ALPHAS)-ALPHA-氨基-N-[(1R)-1-[(3AS,4S,6S,7AR)-六氢-3A,5,5-三甲基-4,6-甲桥-1,3,2-苯并二氧硼烷-2-基]-3-甲基丁基]苯丙酰胺盐酸盐 |
205393-21-1 |
| Liraglutide |
利拉鲁肽 |
204656-20-2 |
| BIBN 4096BS |
N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺 |
204697-65-4 |
| Arg34-GLP-1(7-37) |
利拉鲁肽中间体(TFA盐) |
204521-68-6 |
| 3,7,4'-Trihydroxy-5-methoxy-8-prenylflavanone, (2R,3R)- |
(2R,3R)-3,7,4'-三羟基-5-甲氧基-8-异戊烯基二氢黄酮 |
204935-85-3 |
| (S)-3,3-dimethyl-1,7a-dihydro-3H,5H-pyrrolo[1,2-c]oxazol-5-one |
PF-06416498 |
203871-49-2 |
| DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) |
依多曲肽 |
204318-14-9 |
| Cefprozil IMpurity L |
头孢丙烯杂质L |
203007-73-2 |
| SID 487795 |
NSC617145 |
203115-63-3 |
| Safinamide mesylate |
沙芬酰胺甲磺酸盐 |
202825-46-5 |
| 1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺 |
202463-68-1 |
| (S)-2-[4-(4-Chloro-phenyl)-2,3,9-triMethyl-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-6-yl]-acetaMide |
4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-乙酰胺 |
202591-23-9 |
| (3R,4S)-tert-Butyl 3-(1-ethoxyethoxy)-2-oxo-4-phenylazetidine-1-carboxylate |
(3R,4S)-3-(1-乙氧乙氧基)-2-氧-4-苯基-吖丁啶羧酸叔丁基酯 |
201856-57-7 |
| (3R,4S)-1-Benzoyl-3-(1-ethoxyethoxy)-4-phenyl-2-azetidinone |
(3R,4S)-1-苯甲酰-3-(1-乙氧乙氧基)-4-苯基-2-氮杂环丁酮 |
201856-53-3 |
| SB 269970 HYDROCHLORIDE |
SB 269970盐酸盐 |
201038-74-6 |
| 2-Desacetoxy Prasugrel |
普拉格雷杂质 |
201049-78-7 |
| Phosphine oxide, [(2Z)-2-[(3R,4R,5R)-3,5-bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-4-[3-[[(1,1-diMethylethyl)diMethylsilyl]oxy]propoxy]-2-Methylenecyclohexylidene]ethyl]diphenyl- |
艾地骨化醇中间体A环 |
200636-54-0 |
| BENZYLPHOSPHONIC ACID-(AM)2 |
((苄基磷酰基)双(氧基))双(亚甲基)二乙酸酯 |
200716-68-3 |
QQ
微信
